Sunder Biomedical Tech Co Stock

Sunder Biomedical Tech Co P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Sunder Biomedical Tech Co (4115.TWO) as of Aug 21, 2026 is 6.05. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 3.95 — a change of 53.18% (higher).

P/CF

6.05

YoY

53.18%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Sunder Biomedical Tech Co is 2026 6.05 . P/CF (Price-to-Cash-Flow Ratio) of Sunder Biomedical Tech Co was 2025 3.95 . It decreases by 53.18% higher compared to the previous year.
Access this data via the Eulerpool API

Sunder Biomedical Tech Co Stock analysis

What does Sunder Biomedical Tech Co do? Sunder Biomedical Tech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sunder Biomedical Tech Co stock

P/CF (Price-to-Cash-Flow Ratio) of Sunder Biomedical Tech Co is 6.05 in 2026.

P/CF (Price-to-Cash-Flow Ratio) of Sunder Biomedical Tech Co changed from 3.95 to 6.05, representing a 53.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Sunder Biomedical Tech Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Sunder Biomedical Tech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Sunder Biomedical Tech Co

All Key Metrics — Sunder Biomedical Tech Co